1. Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations
- Author
-
Christina Sundal, Christian Wider, Alex Tselis, Ryan J. Uitti, Keith A. Josephs, Jan O. Aasly, Rosa Rademakers, A. Jon Stoessl, Jay A. van Gerpen, Bradley Miller, Zbigniew K. Wszolek, Salvatore Spina, Dennis W. Dickson, Alexandra M. Nicholson, James Y. Garbern, Sigrun Roeber, Owen A. Ross, Matt Baker, Shinsuke Fujioka, Elizabeth A. Shuster, Russell H. Swerdlow, Daniel F. Broderick, Bernardino Ghetti, and Anne Börjesson-Hanson
- Subjects
Adult ,Male ,Levodopa ,Pathology ,medicine.medical_specialty ,Adolescent ,Parkinsonian gait ,Neuroimaging ,Receptor, Macrophage Colony-Stimulating Factor ,Hypokinesia ,Article ,Antiparkinson Agents ,Young Adult ,Leukoencephalopathies ,Tremor ,Image Processing, Computer-Assisted ,medicine ,Humans ,Family ,Gliosis ,Age of Onset ,Resting tremor ,Demyelinating Disorder ,Gait Disorders, Neurologic ,Aged ,Biological Specimen Banks ,Parkinsonism ,Brain ,Parkinson Disease ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,United Kingdom ,Muscle Rigidity ,nervous system diseases ,Neurology ,Mutation ,Hereditary diffuse leukoencephalopathy with spheroids ,Female ,Neurology (clinical) ,Human medicine ,Geriatrics and Gerontology ,medicine.symptom ,Age of onset ,Psychology ,medicine.drug - Abstract
Atypical Parkinsonism associated with white matter pathology has been described in cerebrovascular diseases, mitochondrial cytopathies, osmotic demyelinating disorders, leukoencephalopathies leukodystrophies, and others. Hereditary diffuse leukoencephalopathy with spheroids (HDLS) is an autosomal dominant disorder with symptomatic onset in midlife and death within a few years after symptom onset. Neuroimaging reveals cerebral white matter lesions that are pathologically characterized by noninflammatory myelin loss, reactive astrocytosis, and axonal spheroids. Most cases are caused by mutations in the colony-stimulating factor 1 receptor (CSF1R) gene. We studied neuropathologically verified HDLS patients with CSF1R mutations to assess parkinsonian features. Ten families were evaluated with 16 affected individuals. During the course of the illness, all patients had at least some degree of bradykinesia. Fifteen patients had postural instability, and seven had rigidity. Two patients initially presented with parkinsonian gait and asymmetrical bradykinesia. These two patients and two others exhibited bradykinesia, rigidity, postural instability, and tremor (two with resting) early in the course of the illness. Levodopa/carbidopa therapy in these four patients provided no benefit, and the remaining 12 patients were not treated. The mean age of onset for all patients was about 45 years (range, 18-71) and the mean disease duration was approximately six years (range, 3-11). We also reviewed HDLS patients published prior to the CSF1R discovery for the presence of parkinsonian features. Out of 50 patients, 37 had gait impairments, 8 rigidity, 7 bradykinesia, and 5 resting tremor. Our report emphasizes the presence of atypical Parkinsonism in HDLS due to CSF1R mutations. (c) 2013 Elsevier Ltd. All rights reserved.
- Published
- 2013